These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 12801855

  • 1. Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.
    Hernández JA, Diloy R, Salat D, del Río N, Martínez X, Castellví JM.
    Haematologica; 2003 Jun; 88(6):ECR22. PubMed ID: 12801855
    [No Abstract] [Full Text] [Related]

  • 2. Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma.
    Tsutsumi Y, Tanaka J, Kawamura T, Miura T, Kanamori H, Obara S, Asaka M, Imamura M, Masauzi N.
    Ann Hematol; 2004 Jan; 83(1):58-60. PubMed ID: 14513286
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma.
    Yang SH, Kuo SH.
    Ann Hematol; 2008 Apr; 87(4):325-7. PubMed ID: 17932671
    [No Abstract] [Full Text] [Related]

  • 6. The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
    He YF, Li YH, Wang FH, Jiang WQ, Xu RH, Sun XF, Xia ZJ, Huang HQ, Lin TY, Zhang L, Bao SP, He YJ, Guan ZZ.
    Ann Hematol; 2008 Jun; 87(6):481-5. PubMed ID: 18299831
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.
    Coiffier B.
    Cancer Invest; 2006 Jun; 24(5):548-52. PubMed ID: 16939967
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.
    J Clin Oncol; 2009 Feb 01; 27(4):605-11. PubMed ID: 19075267
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
    Picardi M, Pane F, Quintarelli C, De Renzo A, Del Giudice A, De Divitiis B, Persico M, Ciancia R, Salvatore F, Rotoli B.
    Haematologica; 2003 Nov 01; 88(11):1296-303. PubMed ID: 14607759
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A, Theodorou M, Dourakis SP, Karayiannis P, Sagkana E, Papanikolopoulos K, Archimandritis AJ.
    J Viral Hepat; 2006 Sep 01; 13(9):591-6. PubMed ID: 16907845
    [Abstract] [Full Text] [Related]

  • 15. [Reactivation of hepatitis B virus in patients with hematological neoplasms].
    Takkenberg RB, Zaaijer HL, ten Cate DF, Biemond BJ, Jansen PL, Reesink HW.
    Ned Tijdschr Geneeskd; 2009 May 09; 153(19):926-31. PubMed ID: 19489299
    [No Abstract] [Full Text] [Related]

  • 16. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H, Cai Q, Lin T, Lin X, Liu Y, Gao Y, Peng R.
    Expert Opin Pharmacother; 2009 Oct 09; 10(15):2399-406. PubMed ID: 19761353
    [Abstract] [Full Text] [Related]

  • 17. Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection.
    Arcaini L, Merli M, Rattotti S, Bruno R, Vercelli A, Lucioni M, Riboni R, Paulli M.
    J Clin Oncol; 2011 Jun 20; 29(18):e543-5. PubMed ID: 21482990
    [No Abstract] [Full Text] [Related]

  • 18. [Relationship between Shenzhen HBV genotype and precore/core promoter mutation and antiviral effects].
    Yuan J, Zhou BP, Gong ZJ, Xu LM, Jiang XL, Mizokami M.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar 20; 20(1):30-2. PubMed ID: 16642214
    [Abstract] [Full Text] [Related]

  • 19. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
    Leaw SJ, Yen CJ, Huang WT, Chen TY, Su WC, Tsao CJ.
    Ann Hematol; 2004 May 20; 83(5):270-5. PubMed ID: 15060745
    [Abstract] [Full Text] [Related]

  • 20. [Efficacity of treatment with lamivudine in two patients with severe reactivation of hepatitis B after withdrawal of chemotherapy].
    Seksik P, Nahon S, Lesgourgues B, Cadranel JF, Mariaud De Serre N, Lenoble M, Lahmeck P, Charoud A, Delas N.
    Gastroenterol Clin Biol; 2000 May 20; 24(6-7):671-4. PubMed ID: 10962392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.